Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07740343Recruiting
Randomised, double-blind trial of remimazolam in Postoperative sleep disturbance (PSD) (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Total sleep time. Started Aug 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07740343.